INS and Insulin resistance: Its clinical identification is based on measures of insulin resistance concomitant with elevated plasma insulin levels, visceral adiposity, atherogenic dyslipidemia (consisting of elevated triglycerides and LDL-cholesterol and reduced HDL-cholesterol), endothelial dysfunction, elevated blood pressure, and a hypercoagulable state.